
LEICESTER, England, Sept. 4 (UPI) -- A Swiss drug maker may be able to provide a one-dose H1N1 vaccine instead of the two-dose inoculation required previously, the company said Thursday.
Novartis Pharmaceuticals Corp. of Basel, Switzerland, said, based on studies conducted through the University of Leicester, it may be able to protect people from A(H1N1) infections within two weeks following administration of a one-time vaccine.
Further clinical experimentation on more than 6,000 children and adults was being conducted worldwide, the company said.
"The study suggests that while two doses seem to provide better protection, one dose of our adjuvanted Celtura vaccine may be sufficient to protect adults against the swine flu. This is important information for public health authorities who prepare for vaccination in the coming months with limited vaccine supply" said Dr. Andrin Oswald, chief executive officer of Novartis Vaccines and Diagnostics.
|
|
|
|
|
|
| Additional Health News Stories | |
MIAMI, May 27 (UPI) --
Tropical Storm Beryl neared hurricane strength ahead of its expected landfall Sunday night on the Southeast Coast of the United States, U.S. forecasters said.
|
TEL AVIV, Israel, May 27 (UPI) --
U.S. pop star Madonna requested producers of her Tel Aviv concert build her children a private pool on the grounds of the concert venue, sources told Haaretz.
|
ANCHORAGE, Alaska, May 27 (UPI) --
A black bear didn't go over a river but went to the woods after scampering through residential and industrial areas of Anchorage, Alaska, police said.
|
To avoid a meltdown in 2006, Ford Motor Co. mortgaged the farm putting up its assets – including its Blue Oval logo, and F-150 pickup and iconic Mustang trademarks – to secure $23.5 billion in credit.
|
| Stories | Photos | People | Comments |
View Caption